Mirum Pharmaceuticals Inc (MIRM)
41.50
+0.37
(+0.90%)
USD |
NASDAQ |
Dec 20, 16:00
41.49
-0.01
(-0.02%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly): -15.75% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics Inc | -92.81% |
| Cytokinetics Inc | -34.67K% |
| Amicus Therapeutics Inc | -4.75% |
| Ocugen Inc | -1.14K% |
| Scholar Rock Holding Corp | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.13% |
| Return on Assets | -15.22% |
| Return on Invested Capital | -18.16% |
| Gross Profit Margin (Quarterly) | 76.98% |
| Operating Margin (Quarterly) | -14.03% |
| Return on Net Operating Assets | -29.02% |